SCHEDULE 13G: Wasatch Advisors LP Discloses 5.1% Passive Stake in Inspire Medical Systems

Wasatch Advisors LP has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in Inspire Medical Systems, Inc. as a passive investment.

Summary

• Wasatch Advisors LP, an investment adviser based in Salt Lake City, United States, has reported beneficial ownership of 1,524,107 shares of Common Stock in Inspire Medical Systems, Inc.
• This ownership represents 5.1% of the total class of securities for Inspire Medical Systems, Inc.
• The filing indicates that Wasatch Advisors LP holds sole voting power over 1,090,184 shares and sole dispositive power over all 1,524,107 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it indicates an institutional investor has taken a significant passive stake, which can be seen as a vote of confidence. However, it's a routine disclosure and doesn't contain performance or strategic updates.

Positives

• The disclosure of a 5.1% stake by an institutional investment adviser like Wasatch Advisors LP can be viewed as a vote of confidence in Inspire Medical Systems, Inc. by a professional investor.
• The investment is stated to be for passive purposes, indicating a long-term investment horizon rather than an activist stance.

Risks

• The filing itself does not detail specific risks related to Inspire Medical Systems, Inc. or the investment, beyond the general market risks inherent in holding common stock.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding the future outlook of Inspire Medical Systems, Inc. or Wasatch Advisors LP's investment strategy beyond the passive nature of the stake.

Management Comments

• Mikes Yeates, CEO of Wasatch Advisors LP, certified that 'to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.'

Industry Context

This filing indicates an institutional investor's interest in the medical device sector, specifically in a company like Inspire Medical Systems, Inc., which operates in the sleep apnea treatment space. It reflects ongoing capital allocation by investment firms into established or growing companies within the healthcare industry.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holder provides transparency regarding the company's ownership structure and may signal institutional confidence, potentially influencing investor sentiment.

Key Dates

Keywords

Inspire Medical Systems, Wasatch Advisors LP, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Passive Investment, Medical Devices, Healthcare